CII
BMY icon

Capital International Inc’s Bristol-Myers Squibb BMY Stock Holding History

Capital International Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Sell
79,939
-12,353
-13% -$709K 0.03% 243
2026
Q1 		$5.6M Sell
92,292
-117,856
-56% -$6.87M 0.04% 228
2025
Q4 		$11.3M Sell
210,148
-136,715
-39% -$6.58M 0.09% 193
2025
Q3 		$15.6M Sell
346,863
-380,763
-52% -$17.8M 0.13% 170
2025
Q2 		$33.7M Buy
727,626
+67,015
+10% +$3.29M 0.33% 81
2025
Q1 		$40.3M Buy
660,611
+27,558
+4% +$1.61M 0.49% 62
2024
Q4 		$35.8M Buy
633,053
+18,178
+3% +$1.02M 0.42% 73
2024
Q3 		$31.8M Sell
614,875
-13,995
-2% -$657K 0.4% 76
2024
Q2 		$26.1M Sell
628,870
-287,254
-31% -$12.9M 0.35% 84
2024
Q1 		$49.7M Buy
916,124
+104,666
+13% +$5.33M 0.67% 47
2023
Q4 		$41.6M Buy
811,458
+102,374
+14% +$5.37M 0.65% 42
2023
Q3 		$41.2M Sell
709,084
-15,494
-2% -$949K 0.79% 36
2023
Q2 		$46.3M Buy
724,578
+160,981
+29% +$10.8M 0.84% 32
2023
Q1 		$39.1M Buy
563,597
+104,853
+23% +$7.4M 0.78% 32
2022
Q4 		$33M Sell
458,744
-31,669
-6% -$2.39M 0.71% 37
2022
Q3 		$34.9M Sell
490,413
-229,609
-32% -$16.7M 0.78% 34
2022
Q2 		$55.4M Sell
720,022
-17,962
-2% -$1.37M 0.77% 39
2022
Q1 		$53.9M Buy
+737,984
New +$49.6M 0.6% 60
2015
Q3 		– Sell
-127,100
Closed -$8.46M – 141
2015
Q2 		$8.46M Sell
127,100
-145,000
-53% -$9.56M 0.61% 49
2015
Q1 		$17.6M Sell
272,100
-50,230
-16% -$3.14M 1.32% 19
2014
Q4 		$19M Sell
322,330
-34,200
-10% -$1.93M 1.3% 19
2014
Q3 		$18.2M Sell
356,530
-55,070
-13% -$2.75M 1.14% 21
2014
Q2 		$20M Sell
411,600
-237,800
-37% -$11.7M 1.05% 27
2014
Q1 		$33.7M Sell
649,400
-46,900
-7% -$2.5M 1.49% 17
2013
Q4 		$37M Sell
696,300
-74,000
-10% -$3.77M 1.59% 17
2013
Q3 		$35.6M Sell
770,300
-999,000
-56% -$43.9M 1.58% 16
2013
Q2 		$79.1M Buy
+1,769,300
New +$76.8M 2.87% 8

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Inc's BMY Position: Q2 2026 in Review

Capital International Inc reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $709K and leaving 79,939 shares worth $4.61M. The position accounts for 0.03% of the portfolio, ranked #243.

Capital International Inc first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $79.1M in Q2 2013. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Capital International Inc held 79,939 shares of Bristol-Myers Squibb worth $4.61M as of Q2 2026.
  • Capital International Inc sold 12,353 Bristol-Myers Squibb shares in Q2 2026, an estimated $709K.
  • Bristol-Myers Squibb made up 0.03% of Capital International Inc's portfolio in Q2 2026, its #243 holding.
  • Capital International Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
  • Capital International Inc's Bristol-Myers Squibb position peaked at $79.1M in Q2 2013.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.